When comparing within the IDH mutant gliomas, the same significant difference remained (co-deleted, 1.17% ± 0.32%; non-co-deleted, 1.66% ± 0.34%, P = 8.72 × 10−7, Fig. 2e). Here, IDH2 is linked to central nervous system cancer.